Clinical Trials · NCT01007851
Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- V.K.V. American Hospital, Istanbul
- Enrollment
- 0
- Start date
- Sep 2006
- Locations
- 1 site, Turkey (Türkiye)
- Primary endpoint
- Ongoing pregnancy beyond 20th gestational week